This has not been reported with Anti-CTLA4 or Anti-PD1-L1, but it is plausible that this occurs with both due to inflammation of the gut, infiltration of lymphocytes and loss of mucosa, which results in severe colitis during therapy [62]. The gene discussed is CTLA4; the disease is colitis.